Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ) — Stock Score Summary

Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ) has a MoatMap StockRank of 62/100 based on Quality (59/100), Value (34/100), and Momentum (53/100) factor scores. The current signal is HOLD. Kelun has a highly valuable ADC (antibody-drug conjugate) biotech platform partnered with Merck, which could unlock massive licensing revenues. However, its core business remains generic IV solutions, which dilutes the quality profile.

Sichuan Kelun Pharmaceutical Co., Ltd. is the dominant leader in China's large-volume injection (IV fluid) market, while rapidly transforming into a global oncology innovator. The company's core IV fluid business provides highly stable cash flows, which fund its advanced R&D pipeline in antibody-drug conjugates (ADCs) through its subsidiary, Kelun-Biotech. Its strategic licensing deals with global pharma giants like MSD underscore the world-class value of its innovative drug pipeline.

Key Financial Metrics

Price$5.62
Market Cap$8.6B
P/E (TTM)34.99
P/E (Forward)23.65
Price/Book2.20
Return on Equity5.9%
Return on Invested Capital8.2%
Debt/Equity16.19
Gross Margin46.5%
Operating Margin6.4%
Revenue Growth-3.0%
Dividend Yield1.8%
Free Cash Flow$18M

Sichuan Kelun Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - General industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Sichuan Kelun Pharmaceutical Co., Ltd.’s (002422.SZ) StockRank?
MoatMap’s StockRank for Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ) is 62/100, with a Hold signal. It is a composite of Quality (59), Value (34), and Momentum (53) factor ranks across MoatMap’s 19,000+ stock universe.
Does Sichuan Kelun Pharmaceutical Co., Ltd. have an economic moat?
Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ) has a Quality factor score of 59/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Sichuan Kelun Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ) is Hold, based on a StockRank of 62/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Sichuan Kelun Pharmaceutical Co., Ltd. in?
Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry (China).
Browse all ranked stocks002422.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock